Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 350 | 798 | 1,833 | 2,923 | 3,568 |
| Marketable Securities | 22 | N/A | N/A | N/A | N/A |
| Receivables | 232 | 219 | 254 | 121 | 450 |
| TOTAL | $642 | $1,055 | $2,203 | $3,135 | $4,135 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 54 | 38 | 19 | 0 | 0 |
| TOTAL | $54 | $38 | $19 | $N/A | $N/A |
| Total Assets | $696 | $1,093 | $2,222 | $3,135 | $4,135 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 376 | 262 | 609 | 463 | 768 |
| Other current liabilities | 22 | N/A | N/A | N/A | 214 |
| TOTAL | $398 | $262 | $609 | $463 | $981 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $398 | $262 | $609 | $463 | $981 |
| Shareholders' Equity | |||||
| Common Shares | 7,259 | 7,252 | 7,572 | 7,554 | 6,847 |
| Retained earnings | -9,671 | -9,090 | -8,686 | -7,496 | -6,247 |
| Other shareholders' equity | 728 | 727 | 759 | 758 | 785 |
| TOTAL | $297 | $831 | $1,614 | $2,672 | $3,153 |
| Total Liabilities And Equity | $696 | $1,093 | $2,222 | $3,135 | $4,135 |